Seguridad y Medio Ambiente - N134

Identification of the individual radiosensitivity of workers exposed to ionising radiation is crucial for protecting these workers from the adverse health-and-safety effects of radiation. This study aims to test and vet a new cytogenetic biomarker called G2 assay, which assesses individual radiosensitivity of healthcare personnel in medical diagnosis and treatment using ionising radiation. Another aim is to assess the oxidant/antioxidant status by means of diverse oxidative-stress and antioxidant-capacity biomarkers. Both types of biomarkers will be one more arrow in the quiver of preventive measures for combating ionising radiation exposure risk.